[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Howe-Davies et al., 1980 - Google Patents

Control of maturity-onset diabetes by monitoring fasting blood glucose and body weight

Howe-Davies et al., 1980

Document ID
10711019102439981723
Author
Howe-Davies S
Simpson R
Turner R
Publication year
Publication venue
Diabetes care

External Links

Snippet

The feasibility of reducing the fasting blood glucose (FBG) level to< 6 mmol/L has been studied in all 84 maturity-onset diabetic (MOD) patients in three general practices. Only 35 (48%) were initially “well controlled” by this criterion, although 72 (86%) had no postprandial …
Continue reading at diabetesjournals.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/14517—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for sweat
    • A61B5/14521—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for sweat using means for promoting sweat production, e.g. heating the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references

Similar Documents

Publication Publication Date Title
Howe-Davies et al. Control of maturity-onset diabetes by monitoring fasting blood glucose and body weight
Nathan et al. Retinopathy in older type II diabetics association with glucose control
Grunt et al. Blood sugar, serum insulin and free fatty acid interrelationships during intravenous tolbutamide testing in normal young adults and in patients with insulinoma
Ney et al. Decreased insulin requirement and improved control of diabetes in pregnant women given a high-carbohydrate, high-fiber, low-fat diet
Longnecker et al. Insulin and a Sulfonylurea Agent in Non–Insulin-Dependent Diabetes Mellitus
Redhead Incidence of glycosuria and diabetes mellitus in a general practice
Peters et al. Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend
Irsigler et al. Self-monitored blood glucose: the essential biofeedback signal in the diabetic patient's effort to achieve normoglycemia
Kelleher et al. Hypertension in diabetic clinic patients and their siblings
Fraser et al. Glycosylated haemoglobin concentrations in newly diagnosed diabetics before and during treatment.
Lebovitz Clinical utility of oral hypoglycemic agents in the management of patients with noninsulin-dependent diabetes mellitus
Arendt et al. Can melatonin alleviate jet lag?
Muir et al. General practice care of non-insulin-dependent diabetes with fasting blood glucose measurements
Demers et al. Glycosylated hemoglobin levels and self-reported stress in adults with diabetes
Chouinard et al. Phenothiazine-induced ECG abnormalities: effect of a glucose load
Schade et al. Differential diagnosis and therapy of hyperketonemic state
CHERNISH et al. The laboratory response to glucagon dosages used in gastrointestinal examinations
de Cos et al. Diabetic euglycemic ketoacidosis induced by oral antidiabetics type SGLT2i
McCall et al. Home blood glucose monitoring: keystone for modern diabetes care
Kohl et al. Improved control of non-insulin-dependent diabetes mellitus by combined halofenate and chlorpropamide therapy
Young Asheville Project improves patient outcomes, cuts medical costs.
Baker Placebo‐controlled trial of guar in poorly controlled Type II diabetes
Gibb et al. Human isophane or lente insulin? A double blind crossover trial in insulin dependent diabetes mellitus.
Solomon The study and treatment of the obese patient
Chase Monitoring glucose control and use of a diabetes control index in insulin-dependent diabetes mellitus